# Safety and Feasibility Study of Rejuvenair™ for Treating Chronic Bronchitis Patients

> **NCT02483637** · NA · COMPLETED · sponsor: **CSA Medical, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Bronchitis, Chronic
- Cryotherapy Effect

## Interventions

- **DEVICE:** RejuvenAir

## Key facts

- **NCT ID:** NCT02483637
- **Lead sponsor:** CSA Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2019-05
- **Final completion:** 2022-05-20
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02483637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02483637, "Safety and Feasibility Study of Rejuvenair™ for Treating Chronic Bronchitis Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02483637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*